Simultaneous Chemotherapy and Immunotherapy May Be Better for …PR Web (press release)New York, NY (PRWEB) April 11, 2018 — Researchers from Mount Sinai and Sema4, a health information company and Mount Sinai venture, have discovered that.Chemo, Immu… Continue reading
Synthetic Biology Workstation Market Threat of New Entrants and RivalryHealthcare JournalSynthetic Biology Workstation Market research for Americas, APAC, EMEA regions is provided on growth factors and consumer needs. Synthetic Biology Workstation Mark… Continue reading
OncLiveRole of Immunotherapies Emerging in Gastric/GEJ CancersOncLiveWhile immune checkpoint inhibitors, specifically PD-1 inhibitors, are the furthest along in development, there are studies looking at combination immunotherapy regimens. Nivolumab has… Continue reading
Gene therapy heavyweights talk next steps for CAR-TBioPharma DiveNo one can deny that cell and gene therapies have taken the biopharma world by storm over the last year, with the approval of the first three cell/gene therapies that can arguably be call… Continue reading
Northwestern University NewsCenter |
New Methodology Helps Study of Promising Targeted Drug Delivery Scaffold
Northwestern University NewsCenter I’m excited to see where it goes. The study builds on Tullman-Ercek’s earlier work, which found that a single amino acid mutation in the same MS2 bacteriophage scaffold drastically changed its size. Tullman-Ercek serves as a faculty member within … |
Motley Fool |
This Little-Known Company Should Have Gilead’s and Celgene’s Investors Nervous
Motley Fool With Gilead Sciences (NASDAQ:GILD) acquiring Kite Pharmaceuticals and Celgene (NASDAQ:CELG) buying Juno Therapeutics to gain access to their chimeric antigen receptor T cell (CAR T) cancer immunotherapies, you’d think the biggest competition would be … |
Genetic Literacy Project |
Parallelized CRISPR-Cas9 Generates Sequence Variants Genome Wide
Genetic Engineering & Biotechnology News The paper is entitled “Highly parallel genome variant engineering with CRISPR-Cas9,” and it appeared April 9 in Nature Genetics. According to this paper, which was prepared by scientists based at the University of California, Los Angeles, a library … Viewpoint: Anti-biotech activists don’t understand the difference between GMOs and CRISPR cropsGenetic Literacy Project |